These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38965547)

  • 1. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.
    Shouman S; El-Kholy N; Hussien AE; El-Derby AM; Magdy S; Abou-Shanab AM; Elmehrath AO; Abdelwaly A; Helal M; El-Badri N
    Cell Commun Signal; 2024 Jul; 22(1):349. PubMed ID: 38965547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.
    Geng J; Chen L; Yuan Y; Wang K; Wang Y; Qin C; Wu G; Chen R; Zhang Z; Wei D; Du P; Zhang J; Lin P; Zhang K; Deng Y; Xu K; Liu J; Sun X; Guo T; Yang X; Wu J; Jiang J; Li L; Zhang K; Wang Z; Zhang J; Yan Q; Zhu H; Zheng Z; Miao J; Fu X; Yang F; Chen X; Tang H; Zhang Y; Shi Y; Zhu Y; Pei Z; Huo F; Liang X; Wang Y; Wang Q; Xie W; Li Y; Shi M; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2021 Sep; 6(1):347. PubMed ID: 34564690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.
    Helal MA; Shouman S; Abdelwaly A; Elmehrath AO; Essawy M; Sayed SM; Saleh AH; El-Badri N
    J Biomol Struct Dyn; 2022 Feb; 40(3):1109-1119. PubMed ID: 32936048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2.
    Faghihi H
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11992-11994. PubMed ID: 33336782
    [No Abstract]   [Full Text] [Related]  

  • 6. The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
    Avolio E; Carrabba M; Milligan R; Kavanagh Williamson M; Beltrami AP; Gupta K; Elvers KT; Gamez M; Foster RR; Gillespie K; Hamilton F; Arnold D; Berger I; Davidson AD; Hill D; Caputo M; Madeddu P
    Clin Sci (Lond); 2021 Dec; 135(24):2667-2689. PubMed ID: 34807265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.
    Jafarzadeh A; Jafarzadeh S; Nozari P; Mokhtari P; Nemati M
    Scand J Immunol; 2021 Feb; 93(2):e12967. PubMed ID: 32875598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
    Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
    mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE2-independent infection of T lymphocytes by SARS-CoV-2.
    Shen XR; Geng R; Li Q; Chen Y; Li SF; Wang Q; Min J; Yang Y; Li B; Jiang RD; Wang X; Zheng XS; Zhu Y; Jia JK; Yang XL; Liu MQ; Gong QC; Zhang YL; Guan ZQ; Li HL; Zheng ZH; Shi ZL; Zhang HL; Peng K; Zhou P
    Signal Transduct Target Ther; 2022 Mar; 7(1):83. PubMed ID: 35277473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.
    Ulrich H; Pillat MM
    Stem Cell Rev Rep; 2020 Jun; 16(3):434-440. PubMed ID: 32307653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues.
    Qiao J; Li W; Bao J; Peng Q; Wen D; Wang J; Sun B
    Biochem Biophys Res Commun; 2020 Dec; 533(4):867-871. PubMed ID: 33008593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Investigation of SARS-CoV-2 Receptor Protein Distribution along Viral Entry Routes in Humans.
    Bräutigam K; Reinhard S; Galván JA; Wartenberg M; Hewer E; Schürch CM
    Respiration; 2022; 101(6):610-618. PubMed ID: 35038715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
    Stefano GB; Kream RM
    Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
    Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
    Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms.
    Ahmadian E; Hosseiniyan Khatibi SM; Razi Soofiyani S; Abediazar S; Shoja MM; Ardalan M; Zununi Vahed S
    Rev Med Virol; 2021 May; 31(3):e2176. PubMed ID: 33022818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2.
    Hassert M; Geerling E; Stone ET; Steffen TL; Feldman MS; Dickson AL; Class J; Richner JM; Brien JD; Pinto AK
    PLoS Pathog; 2020 Dec; 16(12):e1009163. PubMed ID: 33326500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.